Tag: manufacturing-operations
-
Analytica 2026 Munich
Where Analytical Power Meets the Diagnostics Moat analytica 2026 offered a useful vantage point from which to observe technologies before they become diagnostics. Across the exhibition halls in Munich, analytical capability was visible in many forms: proteomics platforms, mass spectrometry in multiple configurations, sequencing automation, flexible pre-analytical robotics, increasingly sophisticated assay workflows, and a broad…
-
IVD Industry Monograph No. 1
Crossing from Analytical to Diagnostics: The Difficulty is the Moat Most analytical technologies never reach clinical diagnostics—not due to inadequate performance, but because clinical markets demand structural transformation: from flexibility to constraint, standardization and manufacturer accountability. The crossing requires seven simultaneous conditions across three phases. This structural distance is not a barrier to avoid but…
-
The Book – INSIGHT 3
The Same Diagnostic System Can Be Infrastructure in One Market and Strain in Another. Technology may stabilize globally. Deployment never does. Why does this matter now? Diagnostics companies often speak of global scale as though it were a movement towards uniformity. The technology travels. The product receives regulatory approval. The analytical performance remains consistent. Yet…
-
The Book – INSIGHT 2
Integration Secured Scale. It Also Reduced Reversibility. Once laboratories became systems of systems, operational coherence became both a strategic asset and a structural exposure. Why does this matter now? Laboratory integration is usually presented as a straightforward improvement: greater automation, shorter turnaround times, better connectivity and more efficient workflows. All of those benefits are real.…
-
The Book – INSIGHT 1
The IVD Industry Did Not Invent Biology. It Stabilized It. The first industrial achievement of diagnostics was not measurement. It was making trust reproducible. Why does this matter now? Diagnostics innovation is frequently discussed as a sequence of scientific breakthroughs: new biomarkers, greater sensitivity, broader menus and increasingly sophisticated technologies. That description is incomplete. The…